Parenteral Drugs (India) Ltd - ESG Rating & Company Profile powered by AI
Alternative companies in the scoring industry group for Parenteral Drugs (India) Ltd are shownin the table. The report of Parenteral Drugs (India) Ltd uses information from across the internet and also from public filings by Parenteral Drugs (India) Ltd. If you work at Parenteral Drugs (India) Ltd and you wish to licence your ESG aseessment, please contact us.
Parenteral Drugs (India) Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
![Detailed ESG Breakdown](/resource/detailed-esg.png?ts=1725478325797)
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Parenteral Drugs (India) Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
![Peer Companies Benchmark](/resource/peer-benchmark-2.png?ts=1725478325797)
Frequently Asked Questions
Does Parenteral Drugs (India) Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Parenteral Drugs (India) Ltd disclose current and historical energy intensity?
Does Parenteral Drugs (India) Ltd report the average age of the workforce?
Does Parenteral Drugs (India) Ltd reference operational or capital allocation in relation to climate change?
Does Parenteral Drugs (India) Ltd disclose its ethnicity pay gap?
Does Parenteral Drugs (India) Ltd disclose cybersecurity risks?
Does Parenteral Drugs (India) Ltd offer flexible work?
Does Parenteral Drugs (India) Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Parenteral Drugs (India) Ltd disclose the number of employees in R&D functions?
Does Parenteral Drugs (India) Ltd conduct supply chain audits?
Does Parenteral Drugs (India) Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Parenteral Drugs (India) Ltd conduct 360 degree staff reviews?
Does Parenteral Drugs (India) Ltd disclose the individual responsible for D&I?
Does Parenteral Drugs (India) Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Parenteral Drugs (India) Ltd disclose current and / or historical scope 2 emissions?
Does Parenteral Drugs (India) Ltd disclose water use targets?
Does Parenteral Drugs (India) Ltd have careers partnerships with academic institutions?
Did Parenteral Drugs (India) Ltd have a product recall in the last two years?
Does Parenteral Drugs (India) Ltd disclose incidents of discrimination?
Does Parenteral Drugs (India) Ltd allow for Work Councils/Collective Agreements to be formed?
Has Parenteral Drugs (India) Ltd issued a profit warning in the past 24 months?
Does Parenteral Drugs (India) Ltd disclose parental leave metrics?
Does Parenteral Drugs (India) Ltd disclose climate scenario or pathway analysis?
Does Parenteral Drugs (India) Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Parenteral Drugs (India) Ltd disclose the pay ratio of women to men?
Does Parenteral Drugs (India) Ltd support suppliers with sustainability related research and development?
Does Parenteral Drugs (India) Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Parenteral Drugs (India) Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Parenteral Drugs (India) Ltd involved in embryonic stem cell research?
Does Parenteral Drugs (India) Ltd disclose GHG and Air Emissions intensity?
Does Parenteral Drugs (India) Ltd disclose its waste policy?
Does Parenteral Drugs (India) Ltd report according to TCFD requirements?
Does Parenteral Drugs (India) Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Parenteral Drugs (India) Ltd disclose energy use targets?
Does Parenteral Drugs (India) Ltd disclose its Renewable Energy targets?
![Only Subscribers](/resource/reload.png)
Are emissions metrics verified by STBi?
![Only Subscribers](/resource/reload.png)
Does Parenteral Drugs (India) Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Parenteral Drugs (India) Ltd
These potential risks are based on the size, segment and geographies of the company.
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.